Subscribe to RSS
Download PDF
DOI: 10.1055/s-0041-1723095
A Hybrid Approach for Treating Recurrent Renal Cell Carcinoma (RCC) in a Single Kidney with a Tethered Ureter
Funding None.
Abstract
This case highlights a hybrid treatment model used successfully in a patient with complicated recurrent renal cell carcinoma (RCC), following partial nephrectomy, in the context of a single kidney. Scar tissue from previous surgery tethered the ureter to the margin of the lesion and combined with obesity, rendered simple percutaneous intervention challenging. The patient was ultimately successfully treated using a hybrid approach of open surgical access, ureterolysis, and intraoperative ultrasound-guided radiofrequency ablation. This approach optimized the volume of conserved normal renal parenchyma and eliminated the need for postoperative dialysis treatment, with no recurrence at 13 months follow-up.
Publication History
Article published online:
16 March 2021
© 2021. Indian Society of Vascular and Interventional Radiology. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Cohen HT, McGovern FJ. Renal-cell carcinoma. N Engl J Med 2005; 353 (23) 2477-2490
- 2 Escudier B, Porta C, Schmidinger M. et al. ESMO Guidelines Committee. Electronic address:. clinicalguidelines@esmo.org Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2019; 30 (05) 706-720
- 3 Johnson BA, Sorokin I, Cadeddu JA. Ten-year outcomes of renal tumor radio frequency ablation. J Urol 2019; 201 (02) 251-258
- 4 Uhlig J, Kokabi N, Xing M, Kim HS. Ablation versus resection for stage 1A renal cell carcinoma: national variation in clinical management and selected outcomes. Radiology 2018; 288 (03) 889-897
- 5 Cooper CJ, Teleb M, Dwivedi A. et al. Comparative outcome of computed tomography guided percutaneous radiofrequency ablation, partial nephrectomy or radical nephrectomy in the treatment of stage T1 renal cell carcinoma. Rare Tumors 2015; 7 (01) 5583
- 6 Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005; 185 (01) 64-71
- 7 MacLennan S, Imamura M, Lapitan MC. et al. UCAN Systematic Review Reference Group; EAU Renal Cancer Guideline Panel. Systematic review of oncological outcomes following surgical management of localised renal cancer. Eur Urol 2012; 61 (05) 972-993
- 8 Psutka SP, Feldman AS, McDougal WS, McGovern FJ, Mueller P, Gervais DA. Long-term oncologic outcomes after radiofrequency ablation for T1 renal cell carcinoma. Eur Urol 2013; 63 (03) 486-492
- 9 Zhou W, Herwald SE, McCarthy C, Uppot RN, Arellano RS. Radiofrequency ablation, cryoablation and microwave ablation for T1a renal cell carcinoma: A comparative evaluation of therapeutic and renal function outcomes. J Vasc Interv Radiol 2019; 30 (07) 1035-1042
- 10 Martin J, Athreya S. Meta-analysis of cryoablation versus microwave ablation for small renal masses: is there a difference in outcome?. Diagn Interv Radiol 2013; 19 (06) 501-507